-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GMW3KAI/R4ee3x3Jl83xuM09AieS/+ZlUOzT7dtMlyx0BVe5CQ8pRo+Ue1p3cD8o ao89DXfH946dgva5YEzV1w== 0000950159-11-000124.txt : 20110214 0000950159-11-000124.hdr.sgml : 20110214 20110214190351 ACCESSION NUMBER: 0000950159-11-000124 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20101231 FILED AS OF DATE: 20110214 DATE AS OF CHANGE: 20110214 EFFECTIVENESS DATE: 20110214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DEERFIELD MANAGEMENT CO /NY CENTRAL INDEX KEY: 0001009258 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-05366 FILM NUMBER: 11610166 BUSINESS ADDRESS: STREET 1: 780 THIRD AVENUE STREET 2: 37TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2125511600 MAIL ADDRESS: STREET 1: 780 THIRD AVENUE, 37TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 13F-HR 1 deerfield13fhr.txt DEERFIELD MANAGEMENT COMPANY, LP 13F HOLDINGS REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 13F FORM 13F COVER PAGE Report for the Calendar Year or Quarter Ended: December 31, 2010 Check here if Amendment [ ]; Amendment Number: This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Deerfield Management Company, LP Address: 780 Third Avenue, 37th Floor New York, NY 10017 Form 13F File Number: 28-5366 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Flynn Management LLC, its general partner Name: James E. Flynn Title: Managing Member Phone: 212-551-1600 Signature, Place, and Date of Signing: /s/ James E. Flynn New York, NY 2/14/2011 - ------------------ ------------ ---------- [Signature] [City, State] [Date] Report Type (Check only one.): [X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [ ] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager is reported in this report and a portion is reported by other reporting manager(s).)
TITLE OF VALUE SHARES/ SH/ PUT/ INVSTMT OTHER VOTING AUTHORITY NAME OF ISSUER CLASS CUSIP $1000) PRN AMT PRN CALL DISCRETN MANAGERS SOLE SHARED NONE - ------------------------------ ---------------- --------- ------- -------- --------- -------- ------- -------- ------ ------- ALKERMES INC COM 01642T108 70,143 5,711,931 SH DEFINED 01 5,711,931 ALLERGAN INC COM 018490102 4,113 59,900 SH DEFINED 01 59,900 AMERICAN DENTAL PARTNERS INC COM 025353103 4,464 330,441 SH DEFINED 01 330,441 AMERISOURCEBERGEN CORP COM 03073E105 40,900 1,198,716 SH DEFINED 01 1,198,716 AMSURG CORP COM 03232P405 1,183 56,477 SH DEFINED 01 56,477 AMYLIN PHARMACEUTICALS INC NOTE 2.500% 4/1 032346AD0 31,880 32,000,000 PRN DEFINED 01 32,000,000 ANIMAL HEALTH INTL INC COM 03525N109 2,289 795,712 SH DEFINED 01 795,712 ANTARES PHARMA INC COM 036642106 6,207 3,651,467 SH DEFINED 01 3,651,467 ANTHERA PHARMACEUTICALS INC COM 03674U102 3,276 671,285 SH DEFINED 01 671,285 ARDEA BIOSCIENCES IN COM 03969P107 10,089 388,034 SH DEFINED 01 388,034 ARRAY BIOPHARMA INC COM 04269X105 13,748 4,597,846 SH DEFINED 01 4,597,846 BIOSANTE PHARMACEUTICALS INC COM 09065V203 1,251 762,506 SH DEFINED 01 762,506 BRISTOL MYERS SQUIBB CO COM 110122108 39,867 1,505,558 SH DEFINED 01 405,558 CARDINAL HEALTH INC COM 14149Y108 19,155 500,000 SH DEFINED 01 500,000 CELGENE CORP COM 151020104 14,785 250,000 SH DEFINED 01 250,000 CENTENE CORP DEL COM 15135B101 21,438 846,000 SH DEFINED 01 846,000 CERUS CORP COM 157085101 1,432 581,988 SH DEFINED 01 581,988 CHELSEA THERAPEUTICS INTERNAT COM 163428105 8,603 1,147,000 SH DEFINED 01 1,147,000 CIGNA CORP COM 125509109 1,100 30,000 SH DEFINED 01 30,000 CONCEPTUS INC NOTE 2.250% 2/1 206016AA5 23,421 24,145,000 PRN DEFINED 01 24,145,000 CUBIST PHARMACEUTICALS INC COM 229678107 1,571 73,410 SH DEFINED 01 73,410 CUBIST PHARMACEUTICALS INC NOTE 2.500%11/0 229678AD9 28,688 30,000,000 PRN DEFINED 01 30,000,000 CUBIST PHARMACEUTICALS INC NOTE 2.250% 6/1 229678AC1 3,011 3,000,000 PRN DEFINED 01 3,000,000 CVS CAREMARK CORP COM 126650100 58,240 1,675,000 SH DEFINED 01 1,675,000 CYCLACEL PHARMACEUTICALS INC COM 23254L108 1,322 899,600 SH DEFINED 01 899,600 CYTOKINETICS INC COM 23282W100 2,750 1,315,700 SH DEFINED 01 1,315,700 DUSA PHARMACEUTICALS INC COM 266898105 7,392 3,016,965 SH DEFINED 01 3,016,965 EURAND NV ORDINARY COM N31010106 15,379 1,300,030 SH DEFINED 01 1,300,030 EXPRESS SCRIPTS INC COM 302182100 35,338 653,800 SH DEFINED 01 653,800 FLAMEL TECHNOLOGIE SA SPONSORED ADR 338488109 7,108 1,039,208 SH DEFINED 01 1,039,208 FOREST LABORATORIES INC COM 345838106 74,625 2,333,500 SH DEFINED 01 2,333,500 GENTIVA HEALTH SVCS INC COM 37247A102 44,860 1,686,467 SH DEFINED 01 1,686,467 GILEAD SCIENCES INC COM 375558103 1,647 45,441 SH DEFINED 01 45,441 HALOZYME THERAPEUTICS INC COM 40637H109 28,924 3,651,959 SH DEFINED 01 3,651,959 HEARTWARE INTL INC NOTE 3.500%12/1 422368AA8 1,650 1,500,000 PRN DEFINED 01 1,500,000 HI-TECH PHARMACAL INC COM 42840B101 31,284 1,253,867 SH DEFINED 01 1,253,867 HOLOGIC INC FRNT 2.000%12/1 436440AA9 9,388 10,000,000 PRN DEFINED 01 10,000,000 HUMANA INC COM 444859102 18,502 338,000 SH DEFINED 01 338,000 INSPIRE PHARMACEUTICALS INC COM 457733103 19,009 2,262,979 SH DEFINED 01 2,262,979 INSPIRE PHARMACEUTICALS INC COM 457733103 2,100 250,000 CALL DEFINED 01 250,000 INTERMUNE INC COM 45884X103 5,201 142,884 SH DEFINED 01 142,884 INTERMUNE INC COM 45884X103 13,650 375,000 CALL DEFINED 01 375,000 INTERMUNE INC NOTE 0.250% 3/0 45884XAC7 8,363 5,000,000 PRN DEFINED 01 5,000,000 ISTA PHARMACEUTICALS INC COM 45031X204 16,579 3,231,718 SH DEFINED 01 3,231,718 JOHNSON & JOHNSON COM 478160104 3,862 62,444 SH DEFINED 01 62,444 KINETIC CONCEPTS INC COM 49460W208 10,470 250,000 SH DEFINED 01 250,000 KING PHARMACEUTICALS INC NOTE 1.250% 4/0 495582AJ7 31,264 31,500,000 PRN DEFINED 01 31,500,000 K V PHARMACEUTICAL CO NOTE 2.500% 5/1 482740AC1 2,726 5,049,000 PRN DEFINED 01 5,049,000 MAGELLAN HEALTH SERVICES INC COM 559079207 14,657 310,000 SH DEFINED 01 310,000 MANNKIND CORP COM 56400P201 27,001 3,350,000 PUT DEFINED 01 3,350,000 MEDICINES CO COM 584688105 85,431 6,046,070 SH DEFINED 01 6,046,070 MEDICIS PHARMACEUTICAL CORP NOTE 2.500% 6/0 58470KAA2 17,220 16,439,000 PRN DEFINED 01 16,439,000 MERCK & CO COM 58933Y105 40,379 1,120,402 SH DEFINED 01 1,120,402 MERIT MEDICAL SYSTEMS INC COM 589889104 38,574 2,436,750 SH DEFINED 01 2,436,750 MOLINA HEALTHCARE INC COM 60855R100 21,578 774,808 SH DEFINED 01 774,808 MOLINA HEALTHCARE INC NOTE 3.750%10/0 60855RAA8 28,736 29,100,000 PRN DEFINED 01 29,100,000 NEKTAR THERAPEUTICS NOTE 3.250% 9/2 640268AH1 6,523 6,474,000 PRN DEFINED 01 6,474,000 NEUROMETRIX INC COM 641255104 707 1,039,570 SH DEFINED 01 1,039,570 NPS PHARMACEUTICALS INC COM 62936P103 167 21,090 SH DEFINED 01 21,090 NUVASIVE INC COM 670704105 13,159 513,035 SH DEFINED 01 513,035 NUVASIVE INC NOTE 2.250% 3/1 670704AB1 38,877 40,235,000 PRN DEFINED 01 40,235,000 NXSTAGE MEDICAL INC COM 67072V103 35,432 1,424,096 SH DEFINED 01 1,424,096 ONYX PHARMACEUTICALS INC NOTE 4.000% 8/1 683399AB5 53,890 45,333,000 PRN DEFINED 01 45,333,000 ORASURE TECHNOLOGIES INC COM 68554V108 4,124 717,211 SH DEFINED 01 717,211 PACIFIC BIOSCIENCES CALIFOR IN COM 69404D108 36,281 2,280,407 SH DEFINED 01 2,280,407 PFIZER INC COM 717081103 34,939 1,995,400 SH DEFINED 01 1,995,400 PHARMASSET INC COM 71715N106 23,958 550,000 SH DEFINED 01 550,000 PROGENICS PHARMACEUTICALS INC COM 743187106 10,780 1,974,281 SH DEFINED 01 1,974,281 RADNET INC COM 750491102 8,865 3,143,726 SH DEFINED 01 3,143,726 RAPTOR PHARMACEUTICALS INC COM 75382F106 2,159 593,100 SH DEFINED 01 593,100 RIGEL PHARMACEUTICALS INC COM 766559603 45,687 6,067,289 SH DEFINED 01 6,067,289 ROCKWELL MED TECHNOLOGIES INC COM 774374102 6,906 874,194 SH DEFINED 01 874,194 RTI BIOLOGICS INC COM 74975N105 2,919 1,093,437 SH DEFINED 01 1,093,437 SALIX PHARMACEUTICALS INC 2.750% 5/1 795435AC0 54,370 42,685,000 PRN DEFINED 01 42,685,000 SAVIENT PHARMACEUTICALS INC COM 80517Q100 5,570 500,000 PUT DEFINED 01 500,000 SHIRE PLC SPONSORED ADR 82481R106 7,943 109,738 SH DEFINED 01 109,738 ST JUDE MED INC COM 790849103 49,065 1,147,721 SH DEFINED 01 1,147,721 TENGION INC COM 88034G109 1,353 532,624 SH DEFINED 01 532,624 VERTEX PHARMACEUTICALS INC NOTE 3.350%10/0 92532FAN0 15,056 15,000,000 PRN DEFINED 01 15,000,000 VERTEX PHARMACEUTICALS INC COM 92532F100 5,254 150,000 PUT DEFINED 01 150,000 VOLCANO CORPORATION NOTE 2.875% 9/0 928645AA8 1,154 1,000,000 PRN DEFINED 01 1,000,000 YM BIOSCIENCES INC COM 984238105 5,745 2,465,782 SH DEFINED 01 2,465,782 ZIOPHARM ONCO COM 98973P101 447 95,967 SH DEFINED 01 95,967 83 1,549,153
FORM 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 1 Form 13F Information Table Entry Total: 83 Form 13F Information Table Value Total: $1,549,153 (thousands) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. [If there are no entries in this list, state "NONE" and omit the column headings and list entries.] No. Form 13F File Number Name 01 28-11827 Flynn Management LLC -----END PRIVACY-ENHANCED MESSAGE-----